Will your doctor inform you of these other possibilities for treating plaque in your arteries?
1. Treatments for clogged arteries - lawnmower, drano or conventional?
2. Watermelon juice reverses hardening of the arteries
3. http://oc1dean.blogspot.com/2011/08/beets-brain-health.html
As someone from the medical profession mentioned to me once, 'Why would you consider putting inflexible metal items in flexible blood vessels?'
The comparison here:
- Andrew J. Epstein, PhD,
- Lin Yang, MS,
- Feifei Yang, MS and
- Peter W. Groeneveld, MD, MS
+ Author Affiliations
- Correspondence to Peter W. Groeneveld, MD, MS, Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 1229 Blockley Hall, 423 Service Dr, Philadelphia, PA 19104-4155. E-mail petergro@upenn.edu
Abstract
Background—The
Centers for Medicare and Medicaid Services require hospitals performing
carotid artery stenting (CAS) to recertify the
quality of their programs every 2 years, but
currently this involves no explicit comparisons of postprocedure
mortality across
hospitals. Hence, the current recertification
process may fail to identify hospitals that are performing poorly in
relation
to peer institutions. Our objective was to
compare risk-standardized procedural outcomes across US hospitals that
performed
CAS and to identify hospitals with
statistically high postprocedure mortality rates.
Methods and Results—We
conducted a retrospective cohort study of Medicare beneficiaries who
underwent CAS from July 2009 to June 2011 at 927 US
hospitals. Thirty-day risk-standardized
mortality rates were calculated using the Hospital Compare statistical
method, a well-validated
hierarchical generalized linear model that
included both patient-level and hospital-level predictors. Claims were
examined
from 22 708 patients undergoing CAS, with a
crude 30-day mortality rate of 2.0%. Risk-standardized 30-day mortality
rates
after CAS varied from 1.1% to 5.1% (P<0.001 for the difference). Thirteen hospitals had risk-standardized mortality rates that were statistically (P<0.05) higher than the national mean. Conversely, 5 hospitals had risk-standardized mortality rates that were statistically
(P<0.05) lower than the national mean.
Conclusions—We used
administrative claims to identify several CAS hospitals with
excessively high 30-day mortality after carotid stenting.
When combined with information currently used
by Medicare for CAS recertification, such as clinical registry data and
program
reports, clinical outcomes comparisons could
enhance Medicare’s ability to identify hospitals that are questionable
candidates
for recertification.
No comments:
Post a Comment